Dive into the Biopharma Space

Stay up-to-date on major biopharma news, deeper dives into specific companies and biopharma themes, and how it all relates to biopharma partners.

New Era In Alzheimer's Treatments Brings Opportunities

mannyvacchiano9

Jul 14, 2023

Biopharma Bite Sized News - July 10th to 14th 2023

Cell therapy data, cancer trial safety-induced hold, potential mergers, and more.. 💡 Are you a CRO, CMO, or Biopharma vendor? BiopharmIQ...

Jul 7, 2023

Biopharma Bite Sized News - July 3rd to 7th 2023

Alzheimer's FDA approval, atopic dermatitis data, new Alzheimer's studies, and more.. 💡 Are you a CRO, CMO, or Biopharma vendor?...

Jun 30, 2023

Biopharma Bite Sized News - June 26th to 30th 2023

Alzheimer's agitation data, clinical hold lifted, new studies planned, and more.. 💡 Are you a CRO, CMO, or Biopharma vendor? BiopharmIQ...

Jun 27, 2023

New Era In Alzheimer's Treatments Brings Opportunities

BiopharmIQ Biotech Business & Corp Dev INSIGHTS Are you a CRO, CMO, or Biopharma vendor? BiopharmIQ MarketCompass is a market...

Jun 24, 2023

Biopharma News - June 19th to 23rd 2023

Acquisitions, rare disease data, gene therapy approval, and more.. Are you a CRO, CMO, or Biopharma vendor? BiopharmIQ MarketCompass is a...

Jun 16, 2023

Biopharma News - June 12th to June 16th 2023

Acquisitions, Alzheimer's data, collaborations, and more.. Are you a CRO, CMO, or Biopharma vendor? BiopharmIQ MarketCompass is a sales...

Jun 9, 2023

Biopharma Weekly News - June 5th to June 9th 2023

Glioblastoma drug to enter clinic, EHA presentations, clinical hold lifted, and more.. Are you a CRO, CMO, or Biopharma vendor?...

May 26, 2023

Biopharma Weekly News - May 22nd to May 26th 2023

NASH Data, ASCO abstracts released, and M&A Activity. Read below for a look at major news from biopharma companies.. 🧬 Verastem Oncology...

May 20, 2023

Recent Advances in NASH Provide Opportunity for CROs and Clinical Sites

Non-alcohol related fatty liver disease (NAFLD) is a global health challenge In the U.S. alone there are ~94 million cases NASH is a...

May 18, 2023

Upcoming Phase 3 Trial Initiations To Watch For

Here's some upcoming phase 3 clinical trials! *not on clintrials gov* 😉 ⚡ 89bio plans to initiate a phase 3 for Pegozafermin to treat...